期刊文献+

慢性肾脏病非透析患者维生素D水平调查 被引量:1

Vitamin D levels in non-dialysis chronic kidney disease patients
原文传递
导出
摘要 目的 了解慢性肾脏病(CKD)患者维生素D不足及缺乏的患病率及其影响因素,为合理治疗维生素D缺乏提供依据。方法 对506例住院CKD 1~5期非透析患者的临床资料进行回顾性分析。用串联质谱法测定血清25(OH)D3水平,并检测血肌酐(SCr),尿酸(UA),白蛋白(Alb),血清钙(Ca)、磷(P),甲状旁腺激素(PTH),血红蛋白(Hb),计算估计肾小球滤过率(e GFR)等;分析25(OH)D3水平与上述临床指标的关系。结果 506例患者的25(OH)D3平均水平为(17.70±8.77)ng/ml;25(OH)D3不足和缺乏总患病率为90.54%。单因素相关分析显示,25(OH)D3与Scr(r=-0.258,P=0.000),P(r=-0.175,P=0.003),PTH(r=-0.154,P=0.01)呈负相关,与e GFR(r=0.271,P=0.000),Hb(r=0.227,P=0.000),Alb(r=0.186,P=0.002)呈正相关。多元线性回归分析显示,e GFR和Alb是25(OH)D3的独立影响因素。结论 维生素D不足和缺乏在CKD非透析患者中普遍存在。e GFR和Alb是CKD患者维生素D水平的独立影响因素。应在CKD人群中普遍开展维生素D水平检测,早期发现、合理治疗维生素D缺乏。 Objective To investigate the prevalence of vitamin D insufficiency and deficiency in chronic kidney disease (CKD) without dialysis, and explore the factors affecting the vitamin D. Provide the evidence for treatment of these pa- tients. Methods The clinical data of 506 inpatients without dialysis CKD from stage 1 to 5 were analyzed retrospectively. The level of 25 ( OH ) D3, serum creatinin ( SCr), uric acid ( UA ), albumin ( Alb ), calcium ( Ca ), phosphorus ( P ), parathy- roid hormone ( PTH), hemoglobin ( Hb ), estimated GFR were determined. The correlation between 25 ( OH ) D3 and those parameters was analyzed. Results The mean level of 25 (OH) D3 in these 506 patients was ( 17.70 ± 8.77 ) ng/ml. The total prevalence of vitamin D insufficiency and deficiency was 90.54%. Single factor correlation analysis indicated that se- rum 25 (OH) D3 was a significantly negative correlation with Scr( r = - 0. 258, P = 0. 000), P ( r = - 0. 175, P = O. 003 ), PTH (r = -0. 154, P = 0.01 ). serum 25 (OH)D3 was significantly positive correlated with eGFR( r = 0.271, P = 0. 000), Hb(r =0.227,P =0. 000) ,Alb(r =0. 186,P =0. 002). Muhivariable regression analysis showed that 25(OH) D3 was positively correlated with eGFR and Alb. Conclusion The prevalence of 25 (OH)D3 insufficiency and deficiency in pa- tients with CKD is quite high. Alb and eGFR may be the key factors influencing 25 (OH) D3 level. Vitamin D level should be measured early among CKD patients in order to carry out corresponding treatment.
出处 《中华全科医学》 2015年第7期1122-1124,共3页 Chinese Journal of General Practice
基金 浙江省医药卫生科技立项项目(2012KYB175)
关键词 肾功能不全 慢性 维生素D 缺乏 Chronic Kidney disease Vitamin D Deficiency
  • 相关文献

参考文献12

  • 1Kim CS, Kim SW. Vitamin D and chronic kidney disease[ J ]. Korean J Intern Med,2014,29(4) :416-427.
  • 2兰凯,罗群,周芳芳,邬民香,蔡珂丹.帕立骨化醇对糖尿病肾病大鼠蛋白尿的影响[J].中华肾脏病杂志,2012,28(7):524-527. 被引量:10
  • 3Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease [ J ]. Kidney Int, 2009,75 ( 1 ) : 88- 95.
  • 4Martin K J, Gonz61ez EA. Vitamin D supplementation in CKD[ J]. Clin Nephro1,2011,75 (4) :286-293.
  • 5National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease[ J. Am J Kid- ney Dis ,2003,42 (4 Suppl 3 ) : S1-201.
  • 6姜丽,李波,李洋,邹家莅.维生素D实验室检测方法研究进展[J].国际检验医学杂志,2012,33(17):2116-2117. 被引量:8
  • 7Kaseda R, Hosojima M, Sato H, et al. Role of megalin and cubilin in the metabolism of vitamin D ( 3 ) [ J 1- Ther Apher Dial,2011,15 ( Suppl 1 ) :14-17.
  • 8Kidney Disease Improving Global Outcomes(KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD) [ J]. Kidney Int Suppl,2009,76( Suppl 113 ) : S1-S130.
  • 9Icardi A, Paoletti E, De Nicola L, et al. Renal anaemia and EPO hypo- responsiveness associated with vitamin D deficiency:the potential role of inflammation [ J ]. Nephrol Dial Transplant, 2013,28 ( 7 ) : 1672- 1679.
  • 10孙小鹉,于为民.早期慢性肾脏病患者维生素D缺乏和贫血的相关性研究[J].中国药物与临床,2013,13(3):288-290. 被引量:1

二级参考文献42

  • 1Valdivielso JM, Cannata-Andta J, Coil B, et al. A new role for vitamin D receptor activation in chronic kidney disease. Am J Physiol Renal Physiol, 2009, 297: 1502-1509.
  • 2Deb DK, Chert Y, Zhang Z, et al. 1,25-dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-KB pathway. Am J Physiol Renal Physiol, 2009, 296: 1212-1218.
  • 3Zhang Z, Sun L, Wang Y, et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int, 2008, 73: 163-171.
  • 4Li C. Vitamin D and diabetic nephropathy. Curr Diab Rep, 2008, 8: 464-469.
  • 5Kramer A, Van D, Rops A, et al. Induction of glomemlar heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin- angiotensin system. J Am Soc Nephrol, 2006, 17: 2513- 2520.
  • 6Nakhoul F, Ramadan R, Khankin E, et al. Glomerular abundance of nephrin and podoein in experimental nephmtic syndrome:different effects of antiproteinuric therapies. Am J Physiol Renal Physiol, 2005, 289: 880-890.
  • 7Den Hoven M J, Rops AL, Bakker MA, et al. Increased expression of heparanase in overt diabetic nephropathy. Kidney Int, 2006, 70: 2100-2108.
  • 8Tuncdemir M, Ozturk M. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin- induced diabetic nephropathy. Acta Histochem, 2010, 12: 234-241.
  • 9Patel NM, Gutierrez OM, Andress DL, et al. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Internation- al,2010,77:715-720.
  • 10Aucella F,Scalzulli RP,Gatta G,et al. Calcitriol increases burst- forming unit-erythroid proliferation in chronic renal failure, a synergistic effect with r-HuEpo. Nephron Clin Pract,2003,95 : c121-c127.

共引文献16

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部